Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
CereVasc is a medical device company that develops a minimally invasive treatment option for communicating hydrocephalus.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Forte Biosciences is a biotechnology company that focuses on dermatology.
Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Talkiatry provides virtual mental healthcare services covered by insurance, connecting patients with licensed psychiatrists.
Perceptive Advisors has invested in 226 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 21 different industry categories.
Among tracked funding rounds, Apogee Therapeutics received $1.3B in a Post-IPO Debt round. Perceptive Advisors's total known invested capital is $30.3B.
Perceptive Advisors's average investment size is $134.2M across its portfolio of 226 companies.
Recent Perceptive Advisors portfolio additions include SOPHiA GENETICS, IDEAYA Biosciences, CereVasc, Apogee Therapeutics, Relay Therapeutics. These companies were founded in 2020 or later.